(Q37424971)

20 August 2017

1 reference

title

The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors (English)

1 reference

20 August 2017

0 references

0 references

Monika Balzer-Geldsetzer

series ordinal

3

object named as

Monika Balzer-Geldsetzer

1 reference

20 August 2017

5

Richard Dodel

1 reference

20 August 2017

6

Michael Bacher

1 reference

20 August 2017

Jan-Philipp Bach

1

1 reference

20 August 2017

Oliver Deuster

series ordinal

2

1 reference

20 August 2017

Bernhard Meyer

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

115

1 reference

20 August 2017

10

1 reference

20 August 2017

2031-2040

1 reference

Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor

20 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Crystal structure of the macrophage migration inhibitory factor from rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Macrophage migration inhibitory factor: a regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Mechanisms and effectors of MIF-dependent promotion of tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Expression of macrophage migration inhibitory factor in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

MIF signal transduction initiated by binding to CD74

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Macrophage migration inhibitory factor promotes intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

A proinflammatory cytokine inhibits p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Microglia in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

The mononuclear cell infiltrate compared with survival in high-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Impaired capacity for upregulation of MHC class II in tumor-associated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Antigen-presenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Human cytomegalovirus-mediated induction of MIF in fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Macrophage migration inhibitory factor: a probable link between inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Regulation of the CTL response by macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24245

7 January 2021

Identifiers

DOI

10.1002/CNCR.24245

1 reference

20 August 2017

1 reference